Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Standard BioTools Inc. (LAB)
Company Research
Source: Yahoo! Finance
Completed merger with SomaLogic, activating strategy to build scaled leader in life sciences tools and services Combined pro forma revenue for FY2023 totaled $192 million and fortified balance sheet with $565 million in combined pro forma cash, cash equivalents, restricted cash and short-term investments at December 31, 2023 SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Standard BioTools Stand-Alone 2023 Fourth Quarter and Full Year Selected Financial Results Quarter Ended Year Ended (Unaudited, in millions, except percentages) December 31, 2023 December 31, 2023 Revenue GAAP gross margin Non-GAAP gross margin Operating expenses Non-GAAP operating expenses Operating loss Net loss Non-GAAP adjusted EBITDA Cash, cash equivalents, restricted cash and short-term inve
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthGlobeNewswire
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024GlobeNewswire
- Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]Yahoo! Finance
LAB
Earnings
- 2/28/24 - Miss
LAB
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 8-K
- 4/9/24 - Form 4
- LAB's page on the SEC website